Figure 2.
Timeline of ROS1 tirosine kinase inhibitors and FDA approvals since discovery of ROS1-rearrangements in non-small-cell lung cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.